Register and apply for funding opportunities to attend ENU 2015

Endocrine Nurse Update 2015 will have a new spring date due to the move of the SfE BES annual conference to the autumn. Next year it will be held in Birmingham, from 16-17 March 2015 If you are a Nurse Member and require funding assistance, you can apply for an SfE conference grant now. New criteria means that even new Nurse Members may apply immediately for an SfE conference grant to attend Endocrine Nurse Update 2015. At the 15 December 2014 conference grant deadline, we will consider applications for Endocrine Nurse Update 2015 and a number of other meetings. Since these applications are granted on a first come, first served basis, please do not wait for the deadline, apply today. Additional funding for nurses is available from the Association for Multiple Endocrine Neoplasia Disorders' (AMEND) Julia Dunn Award. Register for the event Share the latest advances in endocrine nursing expertise, discover the most recent developments and meet colleagues from around the UK - view the full programme now.
Source: Society for Endocrinology - Category: Endocrinology Source Type: news

Related Links:

P Vaideeswar, M Bhuvan, N GoelJournal of Postgraduate Medicine 2022 68(1):44-47 Pulmonary carcinoid tumors are considered as low-grade neoplasms, seen as centrally located endobronchial masses or as peripheral circumscribed nodules. Calcification or ossification is a known phenomenon, but presentation as large bony mass is extremely uncommon. Herein, we report a case of ossifying bronchial carcinoid along with nodular Hashimoto's thyroiditis as incidental autopsy findings in a 32-year-old patient with a prior recent excision of pituitary macroadenoma. This association suggests the possibility of multiple endocrine neo...
Source: Journal of Postgraduate Medicine - Category: Internal Medicine Authors: Source Type: research
In conclusion, for patients with MEN1-related hypergastrinemia and PanNETs, a duodenal origin of periduodenopancreatic lymph node metastases should be considered, even when current conventional and functional imaging studies do not reveal duodenal tumors preoperatively.
Source: The American Journal of Surgical Pathology - Category: Pathology Tags: Original Articles Source Type: research
CONCLUSIONS: FCH PET/CT has a positive benefit/risk ratio in the detection of HFPTG in case of MEN1 (the data in MEN4 being currently very limited) with the most effective detection rate of current imaging modalities for HFPTG, few pitfalls, and an adequate impact on patient management compared to sestaMIBI SPECT and ultrasonography.PMID:35005879 | DOI:10.23736/S1824-4785.22.03440-9
Source: Quarterly Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Authors: Source Type: research
Exp Ther Med. 2022 Jan;23(1):74. doi: 10.3892/etm.2021.10997. Epub 2021 Nov 24.ABSTRACTAggressive prolactinoma (APRL) is a subgroup of aggressive pituitary tumors (accounting for 10% of all hypophyseal neoplasia) which are defined by: invasion based on radiological and/or histological features, a higher proliferation profile when compared to typical adenomas and rapidly developing resistance to standard medication/protocols in addition to an increased risk of early recurrence. This is a narrative review focusing on APRL in terms of both presentation and management. Upon admission, the suggestive features may include increa...
Source: Experimental and Therapeutic Medicine - Category: General Medicine Authors: Source Type: research
Postoperative hypoparathyroidism from inadequate parathyroid hormone is of concern after multigland resections in multiple endocrine neoplasia type 1 –related primary hyperparathyroidism. We evaluated risk factors, long-term outcomes, and roles of autotransplantation and cryopreservation in postoperative hypoparathyroidism in multiple endocrine neoplasia type 1.
Source: Surgery - Category: Surgery Authors: Source Type: research
Ann Thorac Surg. 2021 Dec 15:S0003-4975(21)02052-X. doi: 10.1016/j.athoracsur.2021.10.065. Online ahead of print.ABSTRACTA 49-year-old male was investigated for symptoms of hypercalcaemia which had been present for 3 months. An initial chest X-ray showed a large anterior mediastinal mass. Subsequent computed tomography (CT) scans also demonstrated a calcified lesion in the uncinate process of the pancreas, and a neck ultrasound showed parathyroid lesions. Given the combination of symptoms and tumours, this raised the possibility of multiple endocrine neoplasia type 1 (MEN-1) as the diagnosis. The lesions were later biopsy-...
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Source Type: research
CONCLUSIONS: Diagnosis of gastrinoma is complex, difficult and controversial. Results of this study confirm that a positive secretin stimulation test allows early diagnosis of gastrinomas, even in the presence of borderline or normal levels of non-stimulated FSG.PMID:34922358 | DOI:10.1210/clinem/dgab903
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Source Type: research
Ann Thorac Surg. 2021 Dec 15:S0003-4975(21)02052-X. doi: 10.1016/j.athoracsur.2021.10.065. Online ahead of print.ABSTRACTA 49-year-old male was investigated for symptoms of hypercalcaemia which had been present for 3 months. An initial chest X-ray showed a large anterior mediastinal mass. Subsequent computed tomography (CT) scans also demonstrated a calcified lesion in the uncinate process of the pancreas, and a neck ultrasound showed parathyroid lesions. Given the combination of symptoms and tumours, this raised the possibility of multiple endocrine neoplasia type 1 (MEN-1) as the diagnosis. The lesions were later biopsy-...
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Source Type: research
CONCLUSIONS: Diagnosis of gastrinoma is complex, difficult and controversial. Results of this study confirm that a positive secretin stimulation test allows early diagnosis of gastrinomas, even in the presence of borderline or normal levels of non-stimulated FSG.PMID:34922358 | DOI:10.1210/clinem/dgab903
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Source Type: research
CONCLUSIONS: We suggest that the tumorigenic potential conferred by the D631Y mutation is lower than that conferred by the C634R/W mutation, but higher than that conferred by C630Y. Thus, the risk level of the RET D631Y variant appears to be higher than that of C630Y and lower than that of C634R/W.PMID:34905813 | DOI:10.3904/kjim.2021.311
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Source Type: research
More News: Conferences | Endocrinology | Funding | Grants | Multiple Endocrine Neoplasia | Multiple Endocrine Neoplasia Syndrome | Nurses | Nursing